NCT05164250Approved For Marketing不适用
Compassionate Use (CU) of REGN5458 for Patients With Relapsed or Refractory Multiple Myeloma (MM)
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- Approved For Marketing
研究概览
简要总结
Provide Compassionate Use' of REGN5458 for Patients with Relapsed or Refractory Multiple Myeloma
详细描述
Compassionate Use requests are only being considered in response to Individual Patient Investigational New Drug (IND) applications.
研究设计
- 研究类型
- Expanded Access
入排标准
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Back Pain Prevention in Multiple Myeloma Using an External Spinal BraceMultiple MyelomaNCT02898064University Hospitals of North Midlands NHS Trust2
招募中
不适用
Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.Vertebral FractureMultiple MyelomaNCT04533217Spine Centre of Southern Denmark90
已完成
2 期
SU5416 in Treating Patients With Refractory or Relapsed Multiple MyelomaMultiple Myeloma and Plasma Cell NeoplasmNCT00006013Fox Chase Cancer Center21
No Longer Available
不适用
Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple MyelomaMultiple Myeloma in RelapseMultiple MyelomaNCT02666209Dana-Farber Cancer Institute
已完成
3 期
A randomised comparison of thalidomide and lenalidomide combinations in myeloma patients of all agesCancerISRCTN49407852niversity of Leeds (UK)4,400